Abstract:Objective HHcy is one of the independent risk factors for either cerebrovascular disease or cognitive impairment. The aim of this study is to investigate the relationship between blood Hcy level and early cognitive impairment in small vessel disease (SVD). Methods The data of SVD patients with no dementia from stroke clinic in our hospital for post-stroke follow-up were consecutively collected. The data included demographic information, vascular risk factors (VRFs) spectrum, cognitive assessment results and etc. The fasting blood Hcy was measured within 1 week after enrollment. HHcy was deflned as plasma Hcy level higher than 15 μmol/L. According to the Hcy test results, the patients were divided into HHcy group (Hcy>15?μmmol/L) and normal homocysteine (NHcy) group (Hcy≤15 μmol/L). Multimodal MRI was performed in all patients within 2 weeks after enrollment. The cognitive scores and imaging feature between the two groups were compared. The correlations of Hcy level with cognitive assessment results as well as with the imaging indices were analyzed. Results (1) A total of 81 SVD patients were enrolled in this study, with average age (64.3±7.4) years old, 65 male patients (80.2%) and 50 patients (61.7%) with mild cognitive impairment. (2) 30 patients (37.0%) in HHcy group and 51 ones (63.0%) in NHcy group. There were more smoking patients in HHcy than in NHcy group. There were no signiflcant difference in age, gender, education years between the two groups. (3) There were significant difference in the attention-executive function assessment such as trail making test B (TMT-B) (P=0.016), digital symbol substitution test (DSST) (P=0.013) and forward digital span test (DS-forward) (P=0.029) scores between the two groups. (4) The proportion of moderate to severe periventricular white matter lesions (PV-WMLs) (63.3% vs 39.2%, P=0.018), deep WMLs (60.0% vs 37.3%, P=0.036) and multiple cerebral microbleedings (CMBs) (36.7% vs 17.3%, P=0.047) in HHcy group were higher than those in NHcy group. The blood Hcy level was correlated with PV-WMLs (r=0.227, P=0.041). (5) After adjusting for PV-WMLs score, Hcy level was positively correlated with TMT-B time (r=0.278, P=0.013), negatively correlated with DSST (r=-0.354, P=0.004) and DS-forward (r=-0.366, P=0.001). Conclusions The blood Hcy level in SVD was signiflcantly correlated with attention-executive function and PV-WMLs. The blood Hcy level might be one of the markers of early cognitive impairment in SVD.

Effect of Qihuangjiannao Capsule on Hyperhomocysteinemia in Vascular Dementia Patients

Xi-Xian-Tong-Shuan Capsule Alleviates Vascular Cognitive Impairment in Chronic Cerebral Hypoperfusion Rats by Promoting White Matter Repair, Reducing Neuronal Loss, and Inhibiting the Expression of Pro-Inflammatory Factors.

[Relationship Between Plasma Total Homocysteine and Mild Cognitive Impairment in Senile Patients with Type 2 Diabetes].

The Effect of Tong-xin-luo Capsule on the Cerebrovascular Reserve Capacity in Vascular Dementia Mice

Effect of hyperbaric oxygen combined with folic acid on clinical efficacy and cognitive function in patients with cerebral small vessel disease

Clinical Effect of Treatment with Dan Hong Injection in Patients with Vascular Dementia

Study on the Correlation between Blood Homocysteine Level and Cognitive Function in Patients with Cerebrovascular Disease

Effect of Low-Dose Levamlodipine Besylate in the Treatment of Vascular Dementia

Meta-Analysis of Plasma Homocysteine Content and Cognitive Function in Elderly Patients with Alzheimer'S Disease and Vascular Dementia

The Efficacy of Yangxue Qingnao Granule for Mild Vascular Cognitive Impairment in Senile Patients with Hypertension

Clinical Effect of Danhong Injection in 40 Patients with Vascular Dementia

Effects of Folic Acid and Vitamin B12 and B6 on Levels of Hcy and Lipids in Blood from Patients with Alzheimer's Disease

Clinical Systematic Observation of Kangxin Capsule Curing Vascular Dementia of Senile Kidney Deficiency and Blood Stagnation Type

[Investigation on Plasma Homocysteine Level and Cognition in Population at High Risk for Stroke in Xi'an].

Clinical Trial of Qianglitianmaduzhong Capsule for Geriatric Hypertension Combined with Routine Treatment

Effect of Plasma Homocysteine Levels and Mild Cognitive Dysfunction on Elderly Type 2 Diabetes

[Clinical Observation on Effect of Baisuifang Oral Liquid in Treating Vascular Dementia].

Research on Donepezil and Huperzine-A's Curative Effect on Vascular Dementia

Effect of shenma yizhi capsule on the contents of nitrogen monoxide and activity of nitricoxide synthase in rats with dementia

Effect of Electroacupuncture and Dihydroergotoxine on Patients with Vascular Dementia

Protective effect of Daming capsule against chronic cerebral ischemia